Article

Optimizing EGFR Mutation Testing in Resource-Limited Settings: A Comparative Analysis of Diagnostic Platforms in Libya

2026-06-29

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Lung cancer mortality is rising in Libya, but access to molecular diagnostics for EGFR mutations—essential for guiding tyrosine kinase inhibitor therapy—remains severely limited. Selecting an appropriate testing platform requires balancing analytical performance against cost and infrastructure constraints. <h4>Methods</h4> We conducted a prospective comparative validation...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 073ce6f9-66be-50d7-a706-26cad69f7dc8
DOI: 10.64898/2026.06.25.26356534

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Optimizing EGFR Mutation Testing in Resource-Limited Settings: A Comparative Analysis of Diagnostic Platforms in LibyaDOI 10.64898/2026.06.25.26356534Read

Epidermal growth factor receptor mutation testing: From conventional to real-time diagnosis of lung cancer.Semantic proximity Read

Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung CancerSemantic proximity Read

Evidence-based best practices for EGFR T790M testing in lung cancer in Canada.Semantic proximity Read

Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging MarketsSemantic proximity Read

Advanced Non-small Cell Lung Cancer: EGFR Mutation Analysis Using Pyrosequencing and the Fully Automated qPCR-Based IdyllaTM System.Semantic proximity Read

Epidermal growth factor receptor T790M testing in progressed lung cancer: A review of sensitive methods for analysis of tissue and liquid biopsy samples.Semantic proximity Read

FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for detecting epidermal growth factor receptor variants in NSCLC.Semantic proximity Read

NSCLC molecular testing in Central and Eastern European countries.Semantic proximity Read

Clinical Performance Evaluation Of The Idylla™ Egfr Mutation Test On Formalin-Fixed Paraffin-Embedded Tissue Of Non-Small Cell Lung CancerSemantic proximity Read

Molecular analysis of genetic mutations in non-small cell lung cancer in Morocco.Semantic proximity Read

Patient-centric thresholding of Cobas® EGFR mutation Test v2 for surveillance of EGFR- mutated metastatic Non-Small Cell Lung CancerSemantic proximity Read

Application of IdyllaTM System for Rapid Evaluation of EGFR Mutation Status in Formalin-Fixed and Paraffin-Embedded Samples of Non-Small Cell Lung Cancer.Semantic proximity Read